ESA Detectors Now Directly Connect with Agilent ChemStation Drivers
News May 04, 2006
ESA Biosciences, Inc., a subsidiary of Magellan Biosciences, Inc., has announced that its Corona® CAD™ and Coulochem III HPLC detectors can now be interfaced to the Agilent ChemStation through a standard USB interface.
This interface is designed to allow control and direct digital data acquisition of ESA’s HPLC detectors in the ChemStation environment.
Establishing this first available, fully integrated, ChemStation driver set was the result of a close collaborative effort between ESA and Agilent.
As the largest installed base of any chromatography software application, the Agilent ChemStation upgrade package (Revision B.02.01) was scheduled for release in March.
According to Agilent, the user interface will significantly improve productivity and ease integration of important specialty HPLC detectors.
The ChemStation B.02.01 will also be available in localized versions in Japanese and Chinese.
"We are quite pleased to have played a significant part in working with Agilent to develop this new compatibility between third-party detectors and the world’s most popular chromatography data platform," said John Christensen, ESA Vice President.
"The results of our collaboration will make things easier, more productive, and more cost-effective for researchers around the world."
ESA’s Corona Charged Aerosol Detector offers all-in-one performance benefits that refractive index (RI), low wavelength (UV), evaporative light scattering (ELS), and chemiluminescence nitrogen (CLN) detector methods lack.
Its performance typically provides ten times the sensitivity of ELS, a broad dynamic detection range over four orders of magnitude, more consistent response factors independent of chemical structure and full gradient capability, delivering for the first time to the HPLC market almost complete universality.
The Coulochem III electrochemical detector represents the acknowledged standard for sensitive and selective detection in HPLC.
With its modular design, the Coulochem III platform can be used with any HPLC system and will never become obsolete.
The detector readily quantifies picogram to femtogram levels of oxidizable or reducible compounds.
Modified Form of Botox Could Replace Opioids as Treatment for Chronic PainNews
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to new research.READ MORE
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE
Tackling Cancer at Ground Zero: Designer Molecule Inhibits Protein TargetNews
A new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers. The new molecule successfully targets a protein that plays a major role in the growth of most cancers.READ MORE